Ernexa Therapeutics Inc. Warrants (ERNAW)
Market Open
1 Sep, 18:33
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 04
-0
-9.8434%
$
394.23K Market Cap
- P/E Ratio
- Div Yield
6,141 Volume
0 Eps
$ 0.04
Previous Close Investors:
Want to track ERNAW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ernexa Therapeutics Inc. Warrants (ERNAW) Statistics
Valuation metrics
Market Cap 394.23K
Enterprise value -3.24M
Trailing P/E (ttm) -0.24
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 1.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12.37K
Average volume (90 days) 20.46K
Price summary
52-Week low 0.04
52-Week high 0.06
Beta -
50-Day moving average 0.06
200-Day moving average 0.07
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.94%
Return on equity -3.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -10.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 2.01%
Book value per share (mrq) 2.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
